AK Medical Holdings Limited (1789.HK) Stock
AK Medical Holdings Limited, an investment holding enterprise, specializes in the research, development, production, and worldwide commercialization of orthopedic joint implants and related medical devices under the AK Medical brand. Its comprehensive product offerings encompass conventional knee, hip, and spine replacement implants, as well as advanced 3D-printed solutions like hip implants, artificial vertebral bodies, and spinal interbody cages.
Valuation
Financials & Margins
Latest News
Valuation & Return Ratios
Peer Comparison
About AK Medical Holdings Limited
AK Medical Holdings Limited, an investment holding enterprise, specializes in the research, development, production, and worldwide commercialization of orthopedic joint implants and related medical devices under the AK Medical brand. Its comprehensive product offerings encompass conventional knee, hip, and spine replacement implants, as well as advanced 3D-printed solutions like hip implants, artificial vertebral bodies, and spinal interbody cages. The company further expands its operations by distributing orthopedic products from third-party manufacturers and by fabricating surgical instruments and medical irrigators. Its diverse client base spans distributors, hospitals, physicians, surgeons, and directly serves patients. Established in Beijing, People's Republic of China, in 2003, AK Medical Holdings Limited functions as a subsidiary of Ximalaya Limited.
AK Medical Holdings Limited is led by CEO Zhijiang Li, employs 981 people, headquartered in Beijing, CN, publicly traded since 2017.
over the past 52 weeks the stock has ranged between $4.75 and $7.15, and currently trades 19.3% below its 52-week high.
Official website: www.ak-medical.net